USS Investment Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.05M | Buy |
36,162
+5,843
| +19% | +$1.21M | 0.03% | 363 |
|
|
2026
Q1 | $6.81M | Buy |
30,319
+815
| +3% | +$203K | 0.03% | 311 |
|
|
2025
Q4 | $7.11M | Hold |
29,504
| – | – | 0.03% | 287 |
|
|
2025
Q3 | $8.08M | Hold |
29,504
| – | – | 0.04% | 264 |
|
|
2025
Q2 | $7.6M | Hold |
29,504
| – | – | 0.05% | 258 |
|
|
2025
Q1 | $6.61M | Hold |
29,504
| – | – | 0.05% | 268 |
|
|
2024
Q4 | $6.75M | Sell |
29,504
-10,564
| -26% | -$2.54M | 0.05% | 307 |
|
|
2024
Q3 | $9.78M | Sell |
40,068
-1,079
| -3% | -$241K | 0.07% | 238 |
|
|
2024
Q2 | $7.89M | Buy |
41,147
+1,295
| +3% | +$263K | 0.06% | 261 |
|
|
2024
Q1 | $7.89M | Buy |
39,852
+7,070
| +22% | +$1.3M | 0.06% | 253 |
|
|
2023
Q4 | $5.64M | Hold |
32,782
| – | – | 0.05% | 334 |
|
|
2023
Q3 | $4.85M | Buy |
32,782
+2,022
| +7% | +$366K | 0.05% | 359 |
|
|
2023
Q2 | $6.72M | Buy |
30,760
+838
| +3% | +$187K | 0.08% | 275 |
|
|
2023
Q1 | $6.55M | Buy |
29,922
+1,837
| +7% | +$399K | 0.09% | 265 |
|
|
2022
Q4 | $5.84M | Buy |
28,085
+549
| +2% | +$121K | 0.08% | 292 |
|
|
2022
Q3 | $6.02M | Sell |
27,536
-7,986
| -22% | -$1.82M | 0.09% | 254 |
|
|
2022
Q2 | $7.45M | Sell |
35,522
-2,208
| -6% | -$470K | 0.07% | 276 |
|
|
2022
Q1 | $9.15M | Buy |
37,730
+5,594
| +17% | +$1.35M | 0.08% | 287 |
|
|
2021
Q4 | $8.37M | Hold |
32,136
| – | – | 0.06% | 314 |
|
|
2021
Q3 | $8.47M | Buy |
32,136
+23,175
| +259% | +$6.34M | 0.07% | 291 |
|
|
2021
Q2 | $2.21M | Hold |
8,961
| – | – | 0.02% | 411 |
|
|
2021
Q1 | $1.74M | Hold |
8,961
| – | – | 0.02% | 429 |
|
|
2020
Q4 | $1.91M | Hold |
8,961
| – | – | 0.02% | 392 |
|
|
2020
Q3 | $1.53M | Hold |
8,961
| – | – | 0.01% | 415 |
|
|
2020
Q2 | $1.72M | Buy |
+8,961
| New | +$1.47M | 0.02% | 374 |
|
|
2017
Q1 | – | Sell |
-83,800
| Closed | -$5.2M | – | 150 |
|
|
2016
Q4 | $5.2M | Sell |
83,800
-6,800
| -8% | -$416K | 0.08% | 131 |
|
|
2016
Q3 | $5.87M | Buy |
+90,600
| New | +$6.03M | 0.09% | 97 |
|
|
2014
Q3 | – | Sell |
-439,793
| Closed | -$22.3M | – | 82 |
|
|
2014
Q2 | $22.3M | Sell |
439,793
-709,679
| -62% | -$35.2M | 0.38% | 73 |
|
|
2014
Q1 | $51.4M | Hold |
1,149,472
| – | – | 0.93% | 55 |
|
|
2013
Q4 | $53.7M | Hold |
1,149,472
| – | – | 1.03% | 48 |
|
|
2013
Q3 | $60.7M | Buy |
1,149,472
+298,172
| +35% | +$14.5M | 1.14% | 48 |
|
|
2013
Q2 | $38.4M | Buy |
+851,300
| New | +$40.4M | 0.82% | 62 |
|
Other funds holding RMD
USS Investment Management's RMD Position: Q2 2026 in Review
USS Investment Management increased its ResMed (RMD) stake by 19% in Q2 2026, buying an estimated $1.21M and bringing the position to 36,162 shares worth $7.05M. The position accounts for 0.03% of the portfolio, ranked #363.
USS Investment Management first reported a position in RMD in Q2 2013 and has held it in 32 quarters since. The position peaked at $60.7M in Q3 2013. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- USS Investment Management held 36,162 shares of ResMed worth $7.05M as of Q2 2026.
- USS Investment Management bought 5,843 ResMed shares in Q2 2026, an estimated $1.21M.
- ResMed made up 0.03% of USS Investment Management's portfolio in Q2 2026, its #363 holding.
- USS Investment Management first reported a position in ResMed in Q2 2013 and has held it in 32 quarters since.
- USS Investment Management's ResMed position peaked at $60.7M in Q3 2013.
- 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on USS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.